谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 2 Multiple-Dose Study of an FcRn Inhibitor, Rozanolixizumab, in Patients with Primary Immune Thrombocytopenia.

Tadeusz Robak,Maciej Kazmierczak,Isidro Jarque,Vasile Musteata,Jacek Trelinski,Nichola Cooper,Peter Kiessling,Ute Massow,Franz Woltering,Rose Snipes,Juan Ke,Grant Langdon,Birgit Haier,James B. Bussel,Stephen Jolles

Blood Advances（2020）

引用 74|浏览45
关键词
Immunoglobulin Replacement Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要